| UniProt ID | BACD3_HUMAN | |
|---|---|---|
| UniProt AC | Q9H3F6 | |
| Protein Name | BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 {ECO:0000303|PubMed:19782033} | |
| Gene Name | KCTD10 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 313 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(BACURD3) E3 ubiquitin ligase complex mediates the ubiquitination of target proteins, leading to their degradation by the proteasome (By similarity).. | |
| Protein Sequence | MEEMSGESVVSSAVPAAATRTTSFKGTSPSSKYVKLNVGGALYYTTMQTLTKQDTMLKAMFSGRMEVLTDSEGWILIDRCGKHFGTILNYLRDGAVPLPESRREIEELLAEAKYYLVQGLVEECQAALQNKDTYEPFCKVPVITSSKEEQKLIATSNKPAVKLLYNRSNNKYSYTSNSDDNMLKNIELFDKLSLRFNGRVLFIKDVIGDEICCWSFYGQGRKIAEVCCTSIVYATEKKQTKVEFPEARIYEETLNILLYEAQDGRGPDNALLEATGGAAGRSHHLDEDEERERIERVRRIHIKRPDDRAHLHQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEEMSGES -------CCCCCCCC | 9.93 | 22814378 | |
| 5 | Phosphorylation | ---MEEMSGESVVSS ---CCCCCCCCHHHC | 42.56 | 29083192 | |
| 8 | Phosphorylation | MEEMSGESVVSSAVP CCCCCCCCHHHCCCC | 31.20 | 25627689 | |
| 21 | Phosphorylation | VPAAATRTTSFKGTS CCCCCCCCCCCCCCC | 23.57 | 19691289 | |
| 22 | Phosphorylation | PAAATRTTSFKGTSP CCCCCCCCCCCCCCC | 28.95 | 19691289 | |
| 23 | Phosphorylation | AAATRTTSFKGTSPS CCCCCCCCCCCCCCC | 25.09 | 26055452 | |
| 25 | Ubiquitination | ATRTTSFKGTSPSSK CCCCCCCCCCCCCCC | 62.13 | 21890473 | |
| 25 (in isoform 2) | Ubiquitination | - | 62.13 | 21890473 | |
| 27 | Phosphorylation | RTTSFKGTSPSSKYV CCCCCCCCCCCCCEE | 37.75 | 19691289 | |
| 28 | Phosphorylation | TTSFKGTSPSSKYVK CCCCCCCCCCCCEEE | 31.30 | 19691289 | |
| 30 | Phosphorylation | SFKGTSPSSKYVKLN CCCCCCCCCCEEEEE | 38.95 | 19691289 | |
| 31 | Phosphorylation | FKGTSPSSKYVKLNV CCCCCCCCCEEEEEE | 31.24 | 19691289 | |
| 32 (in isoform 2) | Ubiquitination | - | 59.40 | 21890473 | |
| 32 | Ubiquitination | KGTSPSSKYVKLNVG CCCCCCCCEEEEEEC | 59.40 | 21890473 | |
| 33 (in isoform 1) | Ubiquitination | - | 12.55 | 21890473 | |
| 40 (in isoform 1) | Ubiquitination | - | 14.23 | 21890473 | |
| 52 (in isoform 2) | Ubiquitination | - | 49.65 | 21890473 | |
| 52 | Ubiquitination | TTMQTLTKQDTMLKA ECCHHHCCHHHHHHH | 49.65 | 21906983 | |
| 55 | Phosphorylation | QTLTKQDTMLKAMFS HHHCCHHHHHHHHHH | 23.16 | - | |
| 58 | Ubiquitination | TKQDTMLKAMFSGRM CCHHHHHHHHHHCCC | 27.30 | 21890473 | |
| 60 (in isoform 1) | Ubiquitination | - | 2.34 | 21890473 | |
| 62 | Phosphorylation | TMLKAMFSGRMEVLT HHHHHHHHCCCEEEE | 16.65 | - | |
| 82 | Ubiquitination | ILIDRCGKHFGTILN EEEECCCCCHHHHHH | 39.11 | - | |
| 139 | Ubiquitination | DTYEPFCKVPVITSS CCCCCCCCCCEECCC | 50.37 | - | |
| 147 | Ubiquitination | VPVITSSKEEQKLIA CCEECCCHHHHHHHC | 66.10 | 21906983 | |
| 147 (in isoform 2) | Ubiquitination | - | 66.10 | 21890473 | |
| 151 | Ubiquitination | TSSKEEQKLIATSNK CCCHHHHHHHCCCCC | 45.18 | - | |
| 155 (in isoform 1) | Ubiquitination | - | 26.32 | 21890473 | |
| 158 | Ubiquitination | KLIATSNKPAVKLLY HHHCCCCCCCHHHEE | 33.84 | 21906983 | |
| 158 (in isoform 2) | Ubiquitination | - | 33.84 | 21890473 | |
| 162 (in isoform 2) | Ubiquitination | - | 34.58 | 21890473 | |
| 162 | Ubiquitination | TSNKPAVKLLYNRSN CCCCCCHHHEEECCC | 34.58 | 21890473 | |
| 165 | Phosphorylation | KPAVKLLYNRSNNKY CCCHHHEEECCCCCE | 20.97 | - | |
| 166 (in isoform 1) | Ubiquitination | - | 40.65 | 21890473 | |
| 168 | Phosphorylation | VKLLYNRSNNKYSYT HHHEEECCCCCEEEC | 40.91 | 29083192 | |
| 170 (in isoform 1) | Ubiquitination | - | 45.98 | 21890473 | |
| 171 | Ubiquitination | LYNRSNNKYSYTSNS EEECCCCCEEECCCC | 39.56 | 21890473 | |
| 172 | Phosphorylation | YNRSNNKYSYTSNSD EECCCCCEEECCCCC | 14.72 | 29083192 | |
| 173 | Phosphorylation | NRSNNKYSYTSNSDD ECCCCCEEECCCCCC | 24.44 | 29083192 | |
| 174 | Phosphorylation | RSNNKYSYTSNSDDN CCCCCEEECCCCCCC | 15.88 | 29083192 | |
| 175 | Phosphorylation | SNNKYSYTSNSDDNM CCCCEEECCCCCCCC | 18.58 | 29083192 | |
| 176 | Phosphorylation | NNKYSYTSNSDDNML CCCEEECCCCCCCCH | 26.55 | 29083192 | |
| 179 (in isoform 1) | Ubiquitination | - | 56.40 | 21890473 | |
| 184 | Ubiquitination | NSDDNMLKNIELFDK CCCCCCHHHHHHHHH | 45.14 | 2190698 | |
| 191 | Ubiquitination | KNIELFDKLSLRFNG HHHHHHHHHHHEECC | 32.42 | - | |
| 192 (in isoform 1) | Ubiquitination | - | 6.66 | 21890473 | |
| 193 | Phosphorylation | IELFDKLSLRFNGRV HHHHHHHHHEECCEE | 24.20 | 24719451 | |
| 240 | Phosphorylation | YATEKKQTKVEFPEA HHCCCCCCCCCCCCH | 46.03 | - | |
| 241 | Ubiquitination | ATEKKQTKVEFPEAR HCCCCCCCCCCCCHH | 36.95 | - | |
| 303 | Ubiquitination | RVRRIHIKRPDDRAH HHHHHEECCCCCCCC | 43.65 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BACD3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BACD3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BACD3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BACD2_HUMAN | TNFAIP1 | physical | 22810651 | |
| PCNA_HUMAN | PCNA | physical | 19125419 | |
| NOTC1_HUMAN | NOTCH1 | physical | 25401743 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |